Full Text Journal Articles by
Author Rena M Conti

Advertisement

Find full text journal articles






Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 Diabetes.

Kao-Ping Chua, Joyce M Lee, Rena M Conti,

JAMA Intern Med (JAMA internal medicine)
[2020, :]

Cited: 0 times

View full text PDF listing >>



Relationship between initiation of 340B participation and hospital safety-net engagement.

Sayeh S Nikpay, Melinda B Buntin, Rena M Conti,

OBJECTIVE:The 340B program allows safety-net hospitals to acquire discounted outpatient drugs and charge payers full price. We examined whether 340B participation increases safety-net engagement. DATA SOURCES:340B participation data, Medicare hospital cost reports, American Hospital Association Survey, and Schedule 990 nonprofit hospital tax returns. STUDY DESIGN:Quasi-experimental difference-in-differences design comparing 340B hospitals ... Read more >>

Health Serv Res (Health services research)
[2020, 55(2):157-169]

Cited: 0 times

View full text PDF listing >>



Advertisement

Pediatric Orphan Drug Indications: 2010-2018.

Lauren Kimmel, Rena M Conti, Anna Volerman, Kao-Ping Chua,

BACKGROUND:Orphan drug development is crucial for children, who are disproportionately affected by rare diseases. Data are lacking on the number, nature, and benefit of recently approved pediatric orphan indications. METHODS:We classified the 402 orphan indications the US Food and Drug Administration approved between 2010 and 2018 as "pediatric" if they ... Read more >>

Pediatrics (Pediatrics)
[2020, 145(4):]

Cited: 0 times

View full text PDF listing >>



Differences in the Receipt of Low-Value Services Between Publicly and Privately Insured Children.

Kao-Ping Chua, Aaron L Schwartz, Anna Volerman, Rena M Conti, Elbert S Huang,

BACKGROUND:Children frequently receive low-value services that do not improve health, but it is unknown whether the receipt of these services differs between publicly and privately insured children. METHODS:We analyzed 2013-2014 Medicaid Analytic eXtract and IBM MarketScan Commercial Claims and Encounters databases. Using 20 measures of low-value care (6 diagnostic testing ... Read more >>

Pediatrics (Pediatrics)
[2020, 145(2):]

Cited: 0 times

View full text PDF listing >>



ASHP Foundation Pharmacy Forecast 2020: Strategic Planning Advice for Pharmacy Departments in Hospitals and Health Systems.

Lee C Vermeulen, Meghan D Swarthout, G Caleb Alexander, Diane B Ginsburg, Katie O Pritchett, Sara J White, Jennifer Tryon, Conrad Emmerich, Todd W Nesbit, William Greene, Erin R Fox, Rena M Conti, Bruce E Scott, Frank Sheehy, Michael J Melby, Mark A Lantzy, James M Hoffman, Scott Knoer, William A Zellmer,

Am J Health Syst Pharm (American Journal of Health-System Pharmacy: AJHP)
[2020, 77(2):84-112]

Cited: 0 times

View full text PDF listing >>



Association of Opioid Prescribing Patterns With Prescription Opioid Overdose in Adolescents and Young Adults.

Kao-Ping Chua, Chad M Brummett, Rena M Conti, Amy Bohnert,

Importance:Safe opioid prescribing practices are critical to mitigate the risk of prescription opioid overdose in adolescents and young adults. However, studies that examine opioid prescribing patterns associated with prescription opioid overdose have mostly focused on older adults. The generalizability of these studies to adolescents and young adults is unclear. Objective:To ... Read more >>

JAMA Pediatr (JAMA pediatrics)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.

Rena M Conti, Sayeh S Nikpay, Melinda B Buntin,

Importance:The federal 340B program lowers the acquisition cost of prescription drugs and places no limits on what hospitals charge payers. Congress established the program to allow 340B profits (the difference between payments and acquisition costs) to subsidize other safety-net services. Little is known about the magnitude of revenues and profits ... Read more >>

JAMA Netw Open (JAMA network open)
[2019, 2(10):e1914141]

Cited: 0 times

View full text PDF listing >>



Financial Toxicity of Prescription Drugs.

Rena M Conti,

Ann. Intern. Med. (Annals of internal medicine)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Trends in the Price per Median and Mean Life-Year Gained Among Newly Approved Cancer Therapies 1995 to 2017.

Alice J Chen, Xiaohan Hu, Rena M Conti, Anupam B Jena, Dana P Goldman,

BACKGROUND:The prices of newly approved cancer drugs have risen over the past decades. A key policy question is whether the clinical gains offered by these drugs in treating specific cancer indications justify the price increases. OBJECTIVES:To evaluate the price per median and mean life year gained among newly approved cancer ... Read more >>

Value Health (Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research)
[2019, 22(12):1387-1395]

Cited: 0 times

View full text PDF listing >>



Pharmacy Benefit Manager Reform: Lessons From Ohio.

Trevor J Royce, Sheetal Kircher, Rena M Conti,

JAMA (JAMA)
[2019, :]

Cited: 0 times

View full text PDF listing >>



Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids.

Kao-Ping Chua, Chad M Brummett, Rena M Conti, Rebecca L Haffajee, Lisa A Prosser, Amy S B Bohnert,

Importance:Most prescription opioid misuse involves opioids prescribed to others-a form of opioid diversion. However, few indicators of diversion risk exist. Because family members can often access patients' opioids, one such indicator may be the frequency with which opioid prescriptions are filled by patients when their family members are engaged in ... Read more >>

JAMA Netw Open (JAMA network open)
[2019, 2(5):e193673]

Cited: 0 times

View full text PDF listing >>



Out-of-pocket Spending on Orphan Drug Prescriptions Among Commercially Insured Adults in 2014.

Kao-Ping Chua, Rena M Conti,

J Gen Intern Med (Journal of general internal medicine)
[2019, 34(3):338-340]

Cited: 1 time

View full text PDF listing >>



Generic prescription drug price increases: which products will be affected by proposed anti-gouging legislation?

Rena M Conti, Kevin H Nguyen, Meredith B Rosenthal,

Background:In the United States (U.S.), large price increases for selected generic drugs have elicited public outrage. Recent legislative proposals aim to increase price transparency and identify outlier drug "price spikes." It is unknown how many and what types of products would be highlighted by such efforts. Methods:IQVIA Health Incorporated's National ... Read more >>

J Pharm Policy Pract (Journal of pharmaceutical policy and practice)
[2018, 11:29]

Cited: 0 times

View full text PDF listing >>



Diversity of Participants in the 340B Drug Pricing Program for US Hospitals.

Sayeh Nikpay, Melinda Buntin, Rena M Conti,

JAMA Intern Med (JAMA internal medicine)
[2018, 178(8):1124-1127]

Cited: 0 times

View full text PDF listing >>



Appropriately Framing Child Health Care Spending: A Prerequisite for Value Improvement.

Kao-Ping Chua, Rena M Conti, Gary L Freed,

JAMA (JAMA)
[2018, 319(11):1087-1088]

Cited: 1 time

View full text PDF listing >>



Effect of FDA Investigation on Opioid Prescribing to Children After Tonsillectomy/Adenoidectomy.

Kao-Ping Chua, Mark G Shrime, Rena M Conti,

In August 2012, the Food and Drug Administration investigated the safety of codeine use by children after tonsillectomy and/or adenoidectomy, culminating in a black box warning in February 2013. The objective of this study was to evaluate the association between the investigation and opioid prescribing to children undergoing these surgeries.We ... Read more >>

Pediatrics (Pediatrics)
[2017, 140(6):]

Cited: 3 times

View full text PDF listing >>



Biosimilars: Reimbursement Issues in Your Oncology Practice.

Rena M Conti,

J Oncol Pract (Journal of oncology practice)
[2017, 13(9_suppl):12s-14s]

Cited: 1 time

View full text PDF listing >>



Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending.

Stacie B Dusetzina, Rena M Conti, Nancy L Yu, Peter B Bach,

The increasing cost of prescription drugs is a burden for patients and threatens the financial stability of the US health care system. Rebates are a form of price concession paid by a pharmaceutical manufacturer to the health plan sponsor or the pharmacy benefit manager working on the plan's behalf. Proponents ... Read more >>

JAMA Intern Med (JAMA internal medicine)
[2017, 177(8):1185-1188]

Cited: 10 times

View full text PDF listing >>



Mitigating Financial Toxicity Among US Patients With Cancer.

Jonas A de Souza, Rena M Conti,

JAMA Oncol (JAMA oncology)
[2017, 3(6):765-766]

Cited: 4 times

View full text PDF listing >>



Out-of-Pocket Spending Among Commercially Insured Patients for Epinephrine Autoinjectors Between 2007 and 2014.

Kao-Ping Chua, Rena M Conti,

JAMA Intern Med (JAMA internal medicine)
[2017, 177(5):736-739]

Cited: 2 times

View full text PDF listing >>



Policy Diffusion across Disparate Disciplines: Private- and Public-Sector Dynamics Affecting State-Level Adoption of the ACA.

Rena M Conti, David K Jones,

The ACA entails a number of provisions that are profoundly changing the way the states ensure access to medical care, including the expansion of Medicaid and the maintenance of health insurance exchanges. Here, we argue that while federal policy is the originating force of whether these provisions are adopted, individual ... Read more >>

J Health Polit Policy Law (Journal of health politics, policy and law)
[2017, 42(2):377-385]

Cited: 0 times

View full text PDF listing >>



Pharmaceuticals and Public Health.

Rena M Conti, Rebekah E Gee, Joshua M Sharfstein,

JAMA (JAMA)
[2016, 316(20):2083-2084]

Cited: 1 time

View full text PDF listing >>



21st century pharmacovigilance: efforts, roles, and responsibilities.

Peter J Pitts, Hervé Le Louet, Yola Moride, Rena M Conti,

In an era when the number of expedited and conditional review pathways for newly available brand-name drugs and biosimilar medicines to treat serious and life-threatening diseases is increasing, defining pharmacovigilance has never been more crucial. 21st century pharmacovigilance is not merely about uncovering, reporting, and addressing adverse events associated with ... Read more >>

Lancet Oncol. (The Lancet. Oncology)
[2016, 17(11):e486-e492]

Cited: 10 times

View full text PDF listing >>



Use of Low-Value Pediatric Services Among the Commercially Insured.

Kao-Ping Chua, Aaron L Schwartz, Anna Volerman, Rena M Conti, Elbert S Huang,

BACKGROUND:Claims-based measures of "low-value" pediatric services could facilitate the implementation of interventions to reduce the provision of potentially harmful services to children. However, few such measures have been developed. METHODS:We developed claims-based measures of 20 services that typically do not improve child health according to evidence-based guidelines (eg, cough and ... Read more >>

Pediatrics (Pediatrics)
[2016, 138(6):]

Cited: 5 times

View full text PDF listing >>



A Pathway Through the Bundle Jungle.

Blase Polite, Jeffery C Ward, John V Cox, Roscoe F Morton, John Hennessy, Ray Page, Rena M Conti,

J Oncol Pract (Journal of oncology practice)
[2016, 12(6):504-509]

Cited: 11 times

View full text PDF listing >>



Advertisement

Disclaimer
1.1242 s